Thanks to Süddeutsche Zeitung for mentioning our efforts to use the cold plasma technology in ventilated patients in order to reduce the germ load by direct application of the plasma into the mouth and throat area. This could also help patients suffering from Covid-19, in particular as they are additionally endangered by multi-resistant pathogens in the hospital.
We are currently planning the first preclinical studies with clinics in Munich and Regensburg.
In December 2019 we will move into our new offices, located at the Business Campus Garching.
Therefore, we will be partly offline from December 11th to 17th, 2019. Thank you for your understanding.
Our new address: Parkring 32 85748 Garching Germany
terraplasma at MEDICA 2019
November 12, 2019
On Monday, November 18, 2019, Ms. Dr. Julia Zimmermann (CEO) and Ms. Sylvia Cantzler (Project Manager) will be at MEDICA in Düsseldorf to inform themselves about new applications in the field of medical technology with cold atmospheric plasma and to seek contact with potential cooperation partners.
If you attend the fair at the same day and are interested in a personal meeting, please contact Ms. Dr. Zimmermann (+49 89 9545 769-12).
We are looking forward to interesting impressions and conversations!
Sylvia Cantzler presented cold atmospheric plasma at the CEMS-ESA seminar in the Netherlands
August 30, 2019
For the 15th time, international CEMS master students from the Rotterdam School of Management (RSM) gathered at the ESTEC Space Technology Center of the European Space Agency (ESA) in order to find business opportunities on earth based on a space-technology and to develop business concepts out of it.
As part of the event, Sylvia Cantzler was invited to introduce cold atmospheric plasma as well as the terraplasma technologies and current applications. Students on the other hand were asked to develop business cases for potential cold plasma products and applications based on their then newly acquired knowledge.
The CEMS-ESA workshop has been a great opportunity for terraplasma to identify the potential for further developments and the chance to brainstorm outside the box.
We would like to thank Mr Niels Eldering, representing ESA, for the invitation and Mr Bas Jan Veldhoen, for bringing the students and Sylvia Cantzler together and who continuously motivated, supported and encouraged everyone to find unique ideas.
We would also like to thank all the students for their creative and clever ideas, their qualified development and extremely pleasant cooperation. Exciting and convincing business plans have been created!
DLR (German Aerospace Center) project for plasma-activated water granted
August 14, 2019
terraplasma receives funding for the project to extend the shelf life of fruit and vegetables with plasma-activated water
terraplasma’s application “Plasma-activated water (PAW) for the extension of the shelf life of fruit and vegetables” has been granted with a six-digit EUR amount by the German Aerospace Center (Zentrum für Luft- und Raumfahrt e.V.) and the Federal Ministry for Economic Affairs and Energy.
The aim of this project is the development of a functional model for the production of “plasma-activated water” (PAW) in order to reduce bacteria and fungi on fruit and vegetables. The so-called thin-film technology – a further development of the surface micro-discharge technology – is to be used for this purpose, which uses ambient air and energy to generate a cold atmospheric plasma by means of micro-discharges. This reduces the bacterial and fungal load on fruit and vegetables. Consequently, the potential risk of infection for humans is decreased and the shelf life of these products can be prolonged without changing the vitamin or nutrient content.
August 05, 2019
We gladly announce that the grant of our patent application “Electrode assembly and plasma source for generating a non-thermal plasma, and method for operating a plasma source” was promised in the United States.
An overview of our own patents and patent applications as well as patents with license agreements can be found here.
terraplasma receives funding for the project “Air Treatment with Cold Atmospheric Plasma”
July 29, 2019
terraplasma GmbH obtains a six-digit EUR grant for the project “Air Treatment with Cold Atmospheric Plasma” from the funding program “Central Innovation Program for SMEs” (ZIM) of the Federal Ministry for Economic Affairs and Energy (BMWi).
The aim of this project is the development of an air purification module for cleaning the room air using cold atmospheric plasma.
terraplasma ideation workshop
July 26, 2019
terraplasma’s first ideation workshop took place from 24 to 25 July 2019. The aim of this workshop was to use the idea potential of our employees, external partners and shareholders in order to generate new ideas for cold plasma applications. With a joint brainstorming as well as idea sorting and prioritization, 8 ideas for new applications were selected, which were elaborated in group work and presented afterwards. In the course of this workshop, interesting projects were presented, which are now to be exploited within our company.
CE mark approval for the plasma care®
July 04, 2019
terraplasma medical GmbH has successfully completed the CE conformity assessment procedure for the plasma care®. In June all necessary certificates were issued to terraplasma medical GmbH from TÜV Rheinland (notified body). The plasma care® – which can now be marketed in the European Union – is a portable medical device for wound care using cold atmospheric plasma. As a professional device, the plasma care® can now be used by medical experts for the treatment of acute and chronic wounds.
The plasma care® is a handheld and portable medical device. It generates cold atmospheric plasma directly from the surrounding air by means of micro-discharges. Cold atmospheric plasma is a partially ionized gas, which causes localized and temporary formation of micropores with a diameter of few nanometers in the cell membrane. This results from physical as well as chemical processes. Reactive oxygen and nitrogen species such as nitrogen dioxide, hydrogen peroxide and ozone – produced by the plasma – enter the cell via these micropores. In prokaryotic cells (bacteria) the reactive species then react with the free DNA in these microorganisms and inactivate them by inducing DNA oxidation and double-strand breaks. Antibiotic and other resistances (as for example in the case of MRSA) do not have any influence on this mechanism of inactivation and do not impair this. Human eukaryotic cells on the other hand are not harmed by the effects of temporarily applied cold atmospheric plasma, as their DNA is additionally protected by the nuclear membrane. Moreover, cell-biological repair mechanisms provide additional protection (for example the regulation of the cellular redox-balance).
With the development of the plasma care® terraplasma medical GmbH successfully managed to integrate the complex plasma technology into a small, portable and battery-operated handheld device. The plasma care® uses an indirect plasma source based on the SMD (Surface Micro Discharge) technology (patent pending), which guarantees that no current flows through the patient. The plasma care® was developed in such a way that it significantly reduces the bacterial load in in-patient and out-patient wound care settings, especially in infected wounds which are difficult to heal, and even in the case of infections with multi-resistant pathogens. For this purpose, the plasma care® in combination with a spacer (sterile disposable) is placed onto the wound. By touching the capacitive (touch) start button the plasma production is activated and the generated reactive plasma species are transported to the wound surface without any additional flow, i.e. by pure diffusion.
Dr. Julia Zimmermann @ Hello Tomorrow Global Summit 2019
January 11, 2019
We gladly announce that Dr. Julia Zimmermann is one of the speakers at the Hello Tomorrow Global Summit on March 14 and 15, 2019. In her keynote “Cold Plasma – From Space Research to Earth Medicine” she will talk about how newly developed plasma-based therapies, which first were researched at the ISS, can keep patients safe from infections and treat chronic wounds without damaging tissues.
terraplasma is funded by the largest EU research and innovation programme: Horizon2020
August 07, 2018
terraplasma was selected for the SME Instrument Phase 1 of Horizon2020.
With Horizon2020, ground-breaking innovation projects of small and medium-sized businesses, such as innovative ideas for products, services or processes that are ready to conquer global markets, are supported by EU funds. Innovations created by the SME Instrument, which have great market-building potential, will be promoted with staggered funding, in order to revolutionize existing markets or even create entirely new markets. (Further information can be found here.)
As part of a feasibility study of the SME Instrument Phase 1, terraplasma aims to develop a small, mobile, battery-operated device for the treatment of wounds and skin diseases for the consumer sector, the so-called plasma care®home. The aim of the plasma care®home is to bring the technology and effect of cold atmospheric plasma in the home care sector to private households and thus to the end consumer. The field of application is the treatment of the skin and its wounds and / or their diseases with the aim of reducing unwanted microorganisms, regardless of their level of resistance, and thus to support the self-healing powers of the body.
Like its counterpart – the plasma care® for the professional field of application (doctors, clinics, outpatient care services) – the device is based on the principle of surface Micro-Discharge Technology.
terraplasma receives funding for the “plasma refresher”
December 11, 2017
The application “Removal of odours from textiles using cold plasma” from terraplasma GmbH was granted with a six-digit EUR amount by the “Central Innovation Programme for SMEs” of the Federal Ministry of Economic Affairs and Energy.
Within this project a small, mobile end consumer device, the so-called “plasma refresher”, is developed. The “plasma refresher” incorporates a coated plasma source for the generation of cold atmospheric plasma to permanently eliminate odours from textiles within seconds.
It is planned to distribute the “plasma refresher” to private users via license partners.
terraplasma won the pitch competition from Mentimeter
July 07, 2017
terraplasma rocks! terraplasma won against 11 competitors in all categories of the pitch competition from Mentimeter at the ESA event “R(e)volution in Space – Exploring Your New Business” (3.-4. July 2017):
terraplasma GmbH received a Seal of Excellence from the European Commission for the proposal “plasma care – A small, portable cold plasma device for the treatment of chronic and acute wounds” – submitted under the Horizon 2020. The proposal was evaluated by an international panel of independent experts as a high-quality project proposal.
terraplasma medical successfully completes financing
May 10, 2017
In March 2017, our subsidiary company terraplasma medical GmbH successfully completed the first round of major financing (seed). A number of very experienced private investors are funding the company with a seven-figure Euro amount. The money will enable the company to develop and establish market approval of the plasma care® – a mobile, battery-powered medical device for in- and outpatient treatment of chronic and acute wounds using cold plasma, destroying fungi and multi-resistant bacteria.
terraplasma medical – new incubatee at the ESA incubator
August 04, 2016
We are excited to announce that terraplasma medical was accepted as an incubatee in the ESA incubator at Oberpfaffenhoffen near Munich. The ESA incubation center offers a funding of € 50,000 as well as a large international network, technical support and expertise throughout various partnerships (DLR, Airbus, Fraunhofer etc.), office space and further support in business development.
terraplasma medical at the Munich Business Plan Competition
July 25, 2016
Wir freuen uns über die Prämierung von terraplasma medical in der finalen Runde des Münchener Businessplan Wettbewerbs. Von insgesamt 76 teilnehmenden Start-ups wurden neun Finalisten ausgewählt. Die Prämierungsfeier findet am 26. Juli in München statt.
terraplasma GmbH celebrates its 5th anniversary!
May 11, 2016
Anlässlich des 5-jährigen Bestehens von terraplasma: ein großes Dankeschön an unsere Mitarbeiter, Kunden und Kooperationspartner für die erfolgreichen vergangen Jahre!
Wound treatment with medicative plasma
April 15, 2016
In April 2016, an interesting article about cold atmospheric plasmas and their application in the field of wound treatment was published in the new edition of the Physik Journal. This article was supported by helpful explanations of PD Dr. Julia Zimmermann. Read the article here.
Bayerischer Rundfunk (BR): “plasma in medical science”
April 13, 2016
On April 6, 2016 the local radio station Bayerischer Rundfunk (BR) broadcasted an interview with our CEO PD Dr. Julia Zimmermann regarding the topic “plasma in medical science”. Please access the report here.
Launch of the subsidiary company terraplasma medical GmbH
March 24, 2016
We proudly announce that we founded the subsidiary company ”terraplasma medical GmbH” on April 23, 2016. terraplasma medical will develop and sell small cold atmospheric plasma devices for professional wound treatment.